Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructu...
Autors principals: | McAteer, M, Higgins, G |
---|---|
Format: | Internet publication |
Idioma: | English |
Publicat: |
Research Outreach
2022
|
Ítems similars
-
Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers
per: McAteer, M, et al.
Publicat: (2021) -
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting
per: McAteer, MA, et al.
Publicat: (2025) -
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting
per: Martina A. McAteer, et al.
Publicat: (2025-01-01) -
A new roadmap to improve translation of imaging biomarkers
per: Skwarski, M, et al.
Publicat: (2016) -
Chapter 4 - Applications of nanotechnology in molecular imaging of the brain.
per: McAteer, M, et al.
Publicat: (2009)